Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$892M |
| 2 |
Merck
MRK
|
+$858M |
| 3 |
Amgen
AMGN
|
+$857M |
| 4 |
Home Depot
HD
|
+$837M |
| 5 |
Cisco
CSCO
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$776M |
| 2 |
United Parcel Service
UPS
|
+$615M |
| 3 |
Qualcomm
QCOM
|
+$587M |
| 4 |
Alibaba
BABA
|
+$555M |
| 5 |
Eaton
ETN
|
+$508M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 11.88% |
| 4 | Consumer Discretionary | 11.22% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Lands' End
LE
$382M
| $2.51M | ﹤0.01% |
101,170
+3,918
| +4% | +$115K |
|
2602
Lexicon Pharmaceuticals
LXRX
$1.03B
| $2.48M | ﹤0.01% |
423,226
+89,440
| +27% | +$619K |
|
|
CBAY
2603
DELISTED
Cymabay Therapeutics
CBAY
| $2.45M | ﹤0.01% |
539,114
+19,421
| +4% | +$105K |
|
|
CMBM
2604
DELISTED
Cambium Networks
CMBM
| $2.44M | ﹤0.01% |
52,322
+15,242
| +41% | +$604K |
|
|
CAMP
2605
DELISTED
CalAmp Corp.
CAMP
| $2.44M | ﹤0.01% |
9,790
-359
| -4% | -$91.1K |
|
2606
Icon
ICLR
$12.2B
| $2.44M | ﹤0.01% |
12,407
+174
| +1% | +$34.4K |
|
2607
VirnetX Holding Corp
VHC
$56.8M
| $2.43M | ﹤0.01% |
21,815
+579
| +3% | +$72.6K |
|
2608
Kymera Therapeutics
KYMR
$8.25B
| $2.43M | ﹤0.01% |
62,448
+1,114
| +2% | +$67.1K |
|
2609
Bridgewater Bancshares
BWB
$579M
| $2.42M | ﹤0.01% |
150,107
+11,919
| +9% | +$176K |
|
|
CYBR
2610
DELISTED
CyberArk
CYBR
| $2.4M | ﹤0.01% |
18,536
+923
| +5% | +$140K |
|
2611
Team
TISI
$77.7M
| $2.38M | ﹤0.01% |
20,684
-29,495
| -59% | -$3.23M |
|
2612
Praxis Precision Medicines
PRAX
$8.52B
| $2.38M | ﹤0.01% |
4,843
+192
| +4% | +$137K |
|
2613
Rocky Brands
RCKY
$380M
| $2.38M | ﹤0.01% |
44,021
+7,897
| +22% | +$310K |
|
|
GOCO
2614
DELISTED
GoHealth
GOCO
| $2.37M | ﹤0.01% |
13,536
+354
| +3% | +$71.4K |
|
2615
Northern Oil and Gas
NOG
$2.25B
| $2.37M | ﹤0.01% |
195,700
+49,761
| +34% | +$597K |
|
|
CERE
2616
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $2.36M | ﹤0.01% |
171,670
+4,960
| +3% | +$72.6K |
|
2617
Teekay Tankers
TNK
$2.79B
| $2.36M | ﹤0.01% |
169,479
+5,136
| +3% | +$65.3K |
|
2618
Cue Biopharma
CUE
$113M
| $2.35M | ﹤0.01% |
6,422
+275
| +4% | +$113K |
|
2619
American Outdoor Brands
AOUT
$161M
| $2.35M | ﹤0.01% |
93,138
-62,050
| -40% | -$1.33M |
|
2620
Tejon Ranch
TRC
$455M
| $2.35M | ﹤0.01% |
140,037
+262
| +0.2% | +$4.32K |
|
2621
Crinetics Pharmaceuticals
CRNX
$8.87B
| $2.3M | ﹤0.01% |
150,752
+29
| +0% | +$449 |
|
2622
W&T Offshore
WTI
$522M
| $2.3M | ﹤0.01% |
640,556
+24,890
| +4% | +$77.4K |
|
2623
Carter Bankshares
CARE
$785M
| $2.29M | ﹤0.01% |
163,628
+5,656
| +4% | +$68.6K |
|
|
GSKY
2624
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $2.27M | ﹤0.01% |
366,920
+15,502
| +4% | +$88.9K |
|
2625
KRONOS Worldwide
KRO
$708M
| $2.27M | ﹤0.01% |
148,412
+4,498
| +3% | +$67.4K |
|
Similar funds
Charles Schwab's Q1 2021 Portfolio in Review
As of Q1 2021, Charles Schwab held 3,565 positions worth $273B, up 8.3% from $252B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q1 2021 filing shows 168 new, 2,233 increased, 898 reduced and 80 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M. The largest sale was ExxonMobil, an estimated $776M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2021 buy was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M.
- Charles Schwab added most to Broadcom in Q1 2021, an estimated $892M increase.
- Charles Schwab's biggest Q1 2021 reduction was ExxonMobil, cutting an estimated $776M.
- Charles Schwab fully exited Invesco QQQ Trust in Q1 2021, selling an estimated $396M.
- Charles Schwab's ten largest holdings make up 16% of its $273B portfolio in Q1 2021.
- Charles Schwab opened 168 new positions and closed 80 in Q1 2021.
- Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $273B.
Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.